Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria

被引:115
作者
Dincer, Umit [1 ,2 ]
Cakar, Engin [2 ]
Kiralp, M. Zeki [2 ]
Dursun, Hasan [2 ]
机构
[1] GATA Haydarpasa Egitim hastanesi Fizik Tedavi Reh, TR-34668 Kadikoy, Turkey
[2] Haydarpasa Training Hosp, Gulhane Mil Med Acad, Dept Phys Med & Rehabil, Istanbul, Turkey
关键词
ankylosing spondylitis; diagnosis delay; HLA B27; inflammatory back pain;
D O I
10.1007/s10067-007-0727-6
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Ankylosing spondylitis (AS) is a chronic, progressive, and disabling disease. Among the rheumatological diseases, the longest diagnosis delay is still found for AS. The aim of this cross-sectional study is to evaluate the diagnosis delay and possible reasons in AS. A secondary aim is to assess the relation between diagnosis delay and some clinical and laboratory features. One hundred eleven AS patients, (103 male, 8 female) were recruited. A face-to-face interview was applied to take medical history, and a questionnaire that contains some clinical aspects of disease was used. Diagnosis delay was described as the gap between first spondiloarthropathic symptom and correct diagnosis of AS. The average of diagnosis delay was 6.05 +/- 5.08 years. The average age of patients at disease onset was 23.18 +/- 9.59, the average disease duration was 10.44 +/- 8.11, and the average age at diagnosis was 27.88 +/- 11.63. The average diagnosis delay was 5. 3 +/- 3.5 in HLA B 27(+) AS patients, whereas it was 9.2 +/- 7.7 in HLA B 27(-) AS patients (p= 0.037). Diagnosis delay in patients with inflammatory back pain (+) (IBP) at disease onset was lower than IBP (-) patients (3.28 +/- 3.32, 8.57 +/- 8.54; respectively) (p= 0.001). The patients having positive family history had lower diagnosis delay than those with negative family history (4.60 +/- 4.44, 10.00 +/- 2.30; respectively) (p= 0.003). The diagnosis delay is a challenge and an important problem for patients with AS and physicians. HLA B27 and family history should be considered while making new criteria. Inflammatory back pain should be emphasized as the main screening criterion for primary care physicians. These clinical and laboratory features had positive effect on the average diagnosis delay in AS patients. Describing new diagnostic criteria, which is more useful to diagnosis of AS, is necessary.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 31 条
[1]
A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study - Has the classic case misled us? [J].
Boyer, GS ;
Templin, DW ;
Bowler, A ;
Lawrence, RC ;
Everett, DF ;
Heyse, SP ;
CornoniHuntley, J ;
Goring, WP .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (18) :2111-2117
[2]
Braun J, 2002, ANN RHEUM DIS, V61, P51
[3]
Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.3.CO
[4]
2-7
[5]
Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis [J].
Brown, MA ;
Laval, SH ;
Brophy, S ;
Calin, A .
ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (11) :883-886
[6]
CALIN A, 1988, J RHEUMATOL, V15, P1234
[7]
CLINICAL HISTORY AS A SCREENING-TEST FOR ANKYLOSING-SPONDYLITIS [J].
CALIN, A ;
PORTA, J ;
FRIES, JF ;
SCHURMAN, DJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (24) :2613-2614
[8]
CHOU C-T, 1988, Taiwan yixuehui zazhi, V87, P989
[9]
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks [J].
Davis, JC ;
van der Heijde, DM ;
Braun, J ;
Dougados, M ;
Cush, J ;
Clegg, D ;
Inman, RD ;
Kivitz, A ;
Zhou, L ;
Solinger, A ;
Tsuji, W .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) :1557-1562
[10]
Elyan M, 2006, J RHEUMATOL, V33, P12